autologous tumor cell vaccine Latest Research Papers

Bi-shRNA-Furin/GM-CSF-Expressing Autologous Tumor Cell Vaccine

10.32388/mvxxgd ◽

2020 ◽

Author(s):

Keyword(s):

Tumor Cell ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Gm Csf ◽

Autologous Tumor Cell Vaccine

Download Full-text

Autologous Tumor Cell Vaccine

10.32388/55c5rq ◽

2020 ◽

Author(s):

Keyword(s):

Tumor Cell ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1

10.32388/se4efo ◽

2020 ◽

Author(s):

Keyword(s):

Tumor Cell ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

Abstract P4-04-16: Characterization of an autologous tumor cell vaccine against breast cancer in mice

10.1158/1538-7445.sabcs15-p4-04-16 ◽

2016 ◽

Author(s):

S Ravindranathan ◽

SL Kurtz ◽

SG Smith ◽

B Koppolu ◽

KG Nguyen ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cell ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.003 ◽

2015 ◽

Vol 137 ◽

pp. 2-3 ◽

Cited By ~ 2

Author(s):

J. Oh ◽

M. Barve ◽

E.A. Grosen ◽

B.A. Fine ◽

T.P. Heffernan ◽

...

Keyword(s):

Ovarian Cancer ◽

Tumor Cell ◽

Phase Ii Trial ◽

Complete Response ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Randomized Phase Ii ◽

Autologous Tumor Cell Vaccine

Download Full-text

FANG: bi-shRNAifurin and GMCSF DNA-Augmented Autologous Tumor Cell Vaccine: Clinical Results

Gene and Cell Therapy ◽

10.1201/b18002-51 ◽

2015 ◽

pp. 1073-1090

Author(s):

John Nemunaitis ◽

Donald Rao ◽

Neil Senzer

Keyword(s):

Tumor Cell ◽

Clinical Results ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results

Molecular Therapy ◽

10.1016/s1525-0016(16)35637-4 ◽

2014 ◽

Vol 22 ◽

pp. S241-S242

Keyword(s):

Ovarian Cancer ◽

High Risk ◽

Tumor Cell ◽

Phase Ii Trial ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Randomized Phase Ii ◽

Autologous Tumor Cell Vaccine

Download Full-text

620. Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Vaccine (FANG™) in Advanced Cancer of the Liver

Molecular Therapy ◽

10.1016/s1525-0016(16)35633-7 ◽

2014 ◽

Vol 22 ◽

pp. S240 ◽

Cited By ~ 1

Keyword(s):

Tumor Cell ◽

Advanced Cancer ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Gm Csf ◽

Autologous Tumor Cell Vaccine

Download Full-text

High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-1-s1-p208 ◽

2013 ◽

Vol 1 (S1) ◽

Author(s):

Robert O Dillman ◽

Carol DePriest ◽

Stephanie E McClure

Keyword(s):

Tumor Cell ◽

Metastatic Melanoma ◽

Patient Specific ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

High Dose ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

402. Randomized Phase II Trial of Post-Operative Adjuvant Chemotherapy ±FANG™ Autologous Tumor Cell Vaccine in Colorectal Carcinoma with Liver Metastases

Molecular Therapy ◽

10.1016/s1525-0016(16)34737-2 ◽

2013 ◽

Vol 21 ◽

pp. S155

Keyword(s):

Adjuvant Chemotherapy ◽

Colorectal Carcinoma ◽

Tumor Cell ◽

Phase Ii Trial ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Randomized Phase Ii ◽

Autologous Tumor Cell Vaccine

Download Full-text

autologous tumor cell vaccine
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Bi-shRNA-Furin/GM-CSF-Expressing Autologous Tumor Cell Vaccine

Autologous Tumor Cell Vaccine

MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1

Abstract P4-04-16: Characterization of an autologous tumor cell vaccine against breast cancer in mice

Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

FANG: bi-shRNAifurin and GMCSF DNA-Augmented Autologous Tumor Cell Vaccine: Clinical Results

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results

620. Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Vaccine (FANG™) in Advanced Cancer of the Liver

High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine

402. Randomized Phase II Trial of Post-Operative Adjuvant Chemotherapy ±FANG™ Autologous Tumor Cell Vaccine in Colorectal Carcinoma with Liver Metastases

Export Citation Format

autologous tumor cell vaccineRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Bi-shRNA-Furin/GM-CSF-Expressing Autologous Tumor Cell Vaccine

Autologous Tumor Cell Vaccine

MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1

Abstract P4-04-16: Characterization of an autologous tumor cell vaccine against breast cancer in mice

Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

FANG: bi-shRNAifurin and GMCSF DNA-Augmented Autologous Tumor Cell Vaccine: Clinical Results

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results

620. Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Vaccine (FANG™) in Advanced Cancer of the Liver

High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine

402. Randomized Phase II Trial of Post-Operative Adjuvant Chemotherapy ±FANG™ Autologous Tumor Cell Vaccine in Colorectal Carcinoma with Liver Metastases

autologous tumor cell vaccine
Recently Published Documents